Trial Profile
Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: a prospective cohort study
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2018
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics
- 21 Nov 2018 Status changed from not yet recruiting to recruiting.
- 22 Jun 2018 New trial record